IDEA4RC FHIR Implementation Guide
0.1.0 - CI Build
150
IDEA4RC FHIR Implementation Guide
0.1.0 - CI Build
150
IDEA4RC FHIR Implementation Guide, published by IDEA4RC Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/idea4rc/ and changes regularly. See the Directory of published versions
| Draft as of 2025-09-10 |
{
"resourceType" : "CodeSystem",
"id" : "cs-idea4rc-vocab-eu-i4rc",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem cs-idea4rc-vocab-eu-i4rc</b></p><a name=\"cs-idea4rc-vocab-eu-i4rc\"> </a><a name=\"hccs-idea4rc-vocab-eu-i4rc\"> </a><p>This case-sensitive code system <code>http://hl7.eu/fhir/ig/idea4rc/CodeSystem/cs-idea4rc-vocab-eu-i4rc</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style=\"white-space:nowrap\">2000100001<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100001\"> </a></td><td>IDEA4RC_vocab</td></tr><tr><td style=\"white-space:nowrap\">2000100002<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100002\"> </a></td><td>Recurrence</td></tr><tr><td style=\"white-space:nowrap\">2000100003<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100003\"> </a></td><td>Radiation-induced sarcoma</td></tr><tr><td style=\"white-space:nowrap\">2000100004<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100004\"> </a></td><td>HPV-related Multiphenotypic Sinonasal Carcinoma</td></tr><tr><td style=\"white-space:nowrap\">2000100005<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100005\"> </a></td><td>So-called fibrohistiocytic tumours</td></tr><tr><td style=\"white-space:nowrap\">2000100006<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100006\"> </a></td><td>Vascular tumours</td></tr><tr><td style=\"white-space:nowrap\">2000100007<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100007\"> </a></td><td>Pericytic (perivascular) tumours</td></tr><tr><td style=\"white-space:nowrap\">2000100008<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100008\"> </a></td><td>Undifferentiated small round cell sarcomas of bone and soft tissue</td></tr><tr><td style=\"white-space:nowrap\">2000100009<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100009\"> </a></td><td>Endometrial stromal sarcoma</td></tr><tr><td style=\"white-space:nowrap\">2000100010<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100010\"> </a></td><td>Miscellanious mesenchimal tumors</td></tr><tr><td style=\"white-space:nowrap\">2000100011<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100011\"> </a></td><td>Mixed epithelial and mesenchymal tumours</td></tr><tr><td style=\"white-space:nowrap\">2000100012<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100012\"> </a></td><td>Non-keratinizing squamous cell carcinoma: SMARCB1 (INI-1)-deficient Sinonasal Carcinoma</td></tr><tr><td style=\"white-space:nowrap\">2000100013<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100013\"> </a></td><td>Non-keratinizing squamous cell carcinoma: Transitional (cylindrical cell, Schneiderian) carcinoma</td></tr><tr><td style=\"white-space:nowrap\">2000100014<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100014\"> </a></td><td>Spindle cell (sarcomatoid) squamous cell carcinoma: SMARCB1 (INI-1)</td></tr><tr><td style=\"white-space:nowrap\">2000100015<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100015\"> </a></td><td>SMARCB1 (INI-1)-deficient Sinonasal undifferentiated Carcinoma</td></tr><tr><td style=\"white-space:nowrap\">2000100016<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100016\"> </a></td><td>Sinonasal SMARCA4 deficient carcinoma</td></tr><tr><td style=\"white-space:nowrap\">2000100017<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100017\"> </a></td><td>IDH2-mutated sinonasal undifferentiated neoplasm</td></tr><tr><td style=\"white-space:nowrap\">2000100018<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100018\"> </a></td><td>HPV-related Multiphenotypic Sinonasal Carcinoma</td></tr><tr><td style=\"white-space:nowrap\">2000100019<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100019\"> </a></td><td>NTRK-rearranged spindle cell neoplasm (emerging)</td></tr><tr><td style=\"white-space:nowrap\">2000100020<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100020\"> </a></td><td>Middle Ear</td></tr><tr><td style=\"white-space:nowrap\">2000100021<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100021\"> </a></td><td>Oral cavity</td></tr><tr><td style=\"white-space:nowrap\">2000100022<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100022\"> </a></td><td>Periscapular</td></tr><tr><td style=\"white-space:nowrap\">2000100023<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100023\"> </a></td><td>Groin Flap</td></tr><tr><td style=\"white-space:nowrap\">2000100024<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100024\"> </a></td><td>Anterior 2/3 of tongue NOS</td></tr><tr><td style=\"white-space:nowrap\">2000100025<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100025\"> </a></td><td>Fluorodeoxyglucose positron emission tomography</td></tr><tr><td style=\"white-space:nowrap\">2000100026<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100026\"> </a></td><td>Positron emission tomography using other tracers</td></tr><tr><td style=\"white-space:nowrap\">2000100027<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100027\"> </a></td><td>Combined surgical approach</td></tr><tr><td style=\"white-space:nowrap\">2000100028<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100028\"> </a></td><td>Concomitant Systemic Treatment</td></tr><tr><td style=\"white-space:nowrap\">2000100029<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100029\"> </a></td><td>Systemic treatment alone</td></tr><tr><td style=\"white-space:nowrap\">2000100030<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100030\"> </a></td><td>Treatment ended due to comorbidity</td></tr><tr><td style=\"white-space:nowrap\">2000100031<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100031\"> </a></td><td>Preoperative radiotherapy concomitant to systemic treatment</td></tr><tr><td style=\"white-space:nowrap\">2000100032<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100032\"> </a></td><td>Postoperative radiotherapy concomitant to systemic treatment</td></tr><tr><td style=\"white-space:nowrap\">2000100033<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100033\"> </a></td><td>Definitive radiotherapy</td></tr><tr><td style=\"white-space:nowrap\">2000100034<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100034\"> </a></td><td>Definitive radiotherapy concomitant to systemic treatment</td></tr><tr><td style=\"white-space:nowrap\">2000100035<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100035\"> </a></td><td>Two dimensional (2D) radiotherapy</td></tr><tr><td style=\"white-space:nowrap\">2000100036<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100036\"> </a></td><td>Three dimensional (3D) radiotherapy</td></tr><tr><td style=\"white-space:nowrap\">2000100037<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100037\"> </a></td><td>Intensity modulated radiation therapy (IMRT)</td></tr><tr><td style=\"white-space:nowrap\">2000100038<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100038\"> </a></td><td>Volumetric modulated arc therapy (VMAT)</td></tr><tr><td style=\"white-space:nowrap\">2000100039<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100039\"> </a></td><td>Tomotherapy</td></tr><tr><td style=\"white-space:nowrap\">2000100040<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100040\"> </a></td><td>Stereotactic radiotherapy (SBRT)</td></tr><tr><td style=\"white-space:nowrap\">2000100041<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100041\"> </a></td><td>Ultra high dose rate radiotherapy (Flash therapy)</td></tr><tr><td style=\"white-space:nowrap\">2000100042<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100042\"> </a></td><td>Passive scattering</td></tr><tr><td style=\"white-space:nowrap\">2000100043<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100043\"> </a></td><td>Single beam optimization</td></tr><tr><td style=\"white-space:nowrap\">2000100044<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100044\"> </a></td><td>Intensity modulated proton therapy (IMPT)</td></tr><tr><td style=\"white-space:nowrap\">2000100045<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100045\"> </a></td><td>Adaptive radiotherapy</td></tr><tr><td style=\"white-space:nowrap\">2000100046<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100046\"> </a></td><td>Image guided radiotherapy (IGRT)</td></tr><tr><td style=\"white-space:nowrap\">2000100047<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100047\"> </a></td><td>Re-irradiation in field of first radiation</td></tr><tr><td style=\"white-space:nowrap\">2000100048<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100048\"> </a></td><td>Re-irradiation out of field of first radiation</td></tr><tr><td style=\"white-space:nowrap\">2000100049<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100049\"> </a></td><td>Re-irradiation marginal field of first radiation</td></tr><tr><td style=\"white-space:nowrap\">2000100050<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100050\"> </a></td><td>Less than one week</td></tr><tr><td style=\"white-space:nowrap\">2000100051<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100051\"> </a></td><td>More than one week but less than a month</td></tr><tr><td style=\"white-space:nowrap\">2000100052<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100052\"> </a></td><td>More than a month but less than 3 months</td></tr><tr><td style=\"white-space:nowrap\">2000100053<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100053\"> </a></td><td>More than 3 months</td></tr><tr><td style=\"white-space:nowrap\">2000100054<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100054\"> </a></td><td>doxorubicin and vincristine </td></tr><tr><td style=\"white-space:nowrap\">2000100055<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100055\"> </a></td><td>gemcitabine and vincristine</td></tr><tr><td style=\"white-space:nowrap\">2000100056<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100056\"> </a></td><td>high dose cisplatin</td></tr><tr><td style=\"white-space:nowrap\">2000100057<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100057\"> </a></td><td>ifosfamide and etoposide</td></tr><tr><td style=\"white-space:nowrap\">2000100058<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100058\"> </a></td><td>weekly carboplatin</td></tr><tr><td style=\"white-space:nowrap\">2000100059<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100059\"> </a></td><td>weekly cisplatin</td></tr><tr><td style=\"white-space:nowrap\">2000100060<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100060\"> </a></td><td>Vincristine and Doxorubicin and Ifosfamide</td></tr><tr><td style=\"white-space:nowrap\">2000100061<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100061\"> </a></td><td>Methotrexate and Doxorubicin and Cisplatin</td></tr><tr><td style=\"white-space:nowrap\">2000100062<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100062\"> </a></td><td>Methotrexate and Doxorubicin and Ifosfamide</td></tr><tr><td style=\"white-space:nowrap\">2000100063<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100063\"> </a></td><td>Doxorubicin and Cisplatin and Ifosfamide</td></tr><tr><td style=\"white-space:nowrap\">2000100064<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100064\"> </a></td><td>Methotrexate and Vinorelbine</td></tr><tr><td style=\"white-space:nowrap\">2000100065<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100065\"> </a></td><td>Vincristine and Doxorubicin and Cyclophosphamide</td></tr><tr><td style=\"white-space:nowrap\">2000100066<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100066\"> </a></td><td>Doxorubicin and Ifosfamide and Dacarbazine</td></tr><tr><td style=\"white-space:nowrap\">2000100067<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100067\"> </a></td><td>Irinotecan and Vincristine</td></tr><tr><td style=\"white-space:nowrap\">2000100068<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100068\"> </a></td><td>TNF and Melphalan</td></tr><tr><td style=\"white-space:nowrap\">2000100069<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100069\"> </a></td><td>Cyclophosphamide and Vinorelbine</td></tr><tr><td style=\"white-space:nowrap\">2000100070<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100070\"> </a></td><td>high dose Ifosfamide</td></tr><tr><td style=\"white-space:nowrap\">2000100071<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100071\"> </a></td><td>Alive, No Evidence of Disease (NED)</td></tr><tr><td style=\"white-space:nowrap\">2000100072<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100072\"> </a></td><td>Dead of Disease (DOD)</td></tr><tr><td style=\"white-space:nowrap\">2000100073<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100073\"> </a></td><td>Dead of Other Cause (DOC)</td></tr><tr><td style=\"white-space:nowrap\">2000100074<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100074\"> </a></td><td>Dead of Unknown Cause (DUC)</td></tr><tr><td style=\"white-space:nowrap\">2000100075<a name=\"cs-idea4rc-vocab-eu-i4rc-2000100075\"> </a></td><td>Alive With Disease (AWD)</td></tr></table></div>"
},
"url" : "http://hl7.eu/fhir/ig/idea4rc/CodeSystem/cs-idea4rc-vocab-eu-i4rc",
"version" : "0.1.0",
"name" : "CsIdea4rcVocab",
"title" : "IDEA4RC Vocabulary Code System",
"status" : "draft",
"experimental" : false,
"date" : "2025-09-10T15:18:34+00:00",
"publisher" : "IDEA4RC Project",
"contact" : [
{
"name" : "IDEA4RC Project",
"telecom" : [
{
"system" : "url",
"value" : "https://www.idea4rc.eu/"
}
]
},
{
"name" : "IDEA4RC Project",
"telecom" : [
{
"system" : "url",
"value" : "https://www.idea4rc.eu/"
}
]
}
],
"description" : "Temporary coded concepts to be used by this Project waiting for the assignement from international terminologies.",
"jurisdiction" : [
{
"coding" : [
{
"system" : "http://unstats.un.org/unsd/methods/m49/m49.htm",
"code" : "150",
"display" : "Europe"
}
]
}
],
"caseSensitive" : true,
"content" : "complete",
"count" : 75,
"concept" : [
{
"code" : "2000100001",
"display" : "IDEA4RC_vocab"
},
{
"code" : "2000100002",
"display" : "Recurrence"
},
{
"code" : "2000100003",
"display" : "Radiation-induced sarcoma"
},
{
"code" : "2000100004",
"display" : "HPV-related Multiphenotypic Sinonasal Carcinoma"
},
{
"code" : "2000100005",
"display" : "So-called fibrohistiocytic tumours"
},
{
"code" : "2000100006",
"display" : "Vascular tumours"
},
{
"code" : "2000100007",
"display" : "Pericytic (perivascular) tumours"
},
{
"code" : "2000100008",
"display" : "Undifferentiated small round cell sarcomas of bone and soft tissue"
},
{
"code" : "2000100009",
"display" : "Endometrial stromal sarcoma"
},
{
"code" : "2000100010",
"display" : "Miscellanious mesenchimal tumors"
},
{
"code" : "2000100011",
"display" : "Mixed epithelial and mesenchymal tumours"
},
{
"code" : "2000100012",
"display" : "Non-keratinizing squamous cell carcinoma: SMARCB1 (INI-1)-deficient Sinonasal Carcinoma"
},
{
"code" : "2000100013",
"display" : "Non-keratinizing squamous cell carcinoma: Transitional (cylindrical cell, Schneiderian) carcinoma"
},
{
"code" : "2000100014",
"display" : "Spindle cell (sarcomatoid) squamous cell carcinoma: SMARCB1 (INI-1)"
},
{
"code" : "2000100015",
"display" : "SMARCB1 (INI-1)-deficient Sinonasal undifferentiated Carcinoma"
},
{
"code" : "2000100016",
"display" : "Sinonasal SMARCA4 deficient carcinoma"
},
{
"code" : "2000100017",
"display" : "IDH2-mutated sinonasal undifferentiated neoplasm"
},
{
"code" : "2000100018",
"display" : "HPV-related Multiphenotypic Sinonasal Carcinoma"
},
{
"code" : "2000100019",
"display" : "NTRK-rearranged spindle cell neoplasm (emerging)"
},
{
"code" : "2000100020",
"display" : "Middle Ear"
},
{
"code" : "2000100021",
"display" : "Oral cavity"
},
{
"code" : "2000100022",
"display" : "Periscapular"
},
{
"code" : "2000100023",
"display" : "Groin Flap"
},
{
"code" : "2000100024",
"display" : "Anterior 2/3 of tongue NOS"
},
{
"code" : "2000100025",
"display" : "Fluorodeoxyglucose positron emission tomography"
},
{
"code" : "2000100026",
"display" : "Positron emission tomography using other tracers"
},
{
"code" : "2000100027",
"display" : "Combined surgical approach"
},
{
"code" : "2000100028",
"display" : "Concomitant Systemic Treatment"
},
{
"code" : "2000100029",
"display" : "Systemic treatment alone"
},
{
"code" : "2000100030",
"display" : "Treatment ended due to comorbidity"
},
{
"code" : "2000100031",
"display" : "Preoperative radiotherapy concomitant to systemic treatment"
},
{
"code" : "2000100032",
"display" : "Postoperative radiotherapy concomitant to systemic treatment"
},
{
"code" : "2000100033",
"display" : "Definitive radiotherapy"
},
{
"code" : "2000100034",
"display" : "Definitive radiotherapy concomitant to systemic treatment"
},
{
"code" : "2000100035",
"display" : "Two dimensional (2D) radiotherapy"
},
{
"code" : "2000100036",
"display" : "Three dimensional (3D) radiotherapy"
},
{
"code" : "2000100037",
"display" : "Intensity modulated radiation therapy (IMRT)"
},
{
"code" : "2000100038",
"display" : "Volumetric modulated arc therapy (VMAT)"
},
{
"code" : "2000100039",
"display" : "Tomotherapy"
},
{
"code" : "2000100040",
"display" : "Stereotactic radiotherapy (SBRT)"
},
{
"code" : "2000100041",
"display" : "Ultra high dose rate radiotherapy (Flash therapy)"
},
{
"code" : "2000100042",
"display" : "Passive scattering"
},
{
"code" : "2000100043",
"display" : "Single beam optimization"
},
{
"code" : "2000100044",
"display" : "Intensity modulated proton therapy (IMPT)"
},
{
"code" : "2000100045",
"display" : "Adaptive radiotherapy"
},
{
"code" : "2000100046",
"display" : "Image guided radiotherapy (IGRT)"
},
{
"code" : "2000100047",
"display" : "Re-irradiation in field of first radiation"
},
{
"code" : "2000100048",
"display" : "Re-irradiation out of field of first radiation"
},
{
"code" : "2000100049",
"display" : "Re-irradiation marginal field of first radiation"
},
{
"code" : "2000100050",
"display" : "Less than one week"
},
{
"code" : "2000100051",
"display" : "More than one week but less than a month"
},
{
"code" : "2000100052",
"display" : "More than a month but less than 3 months"
},
{
"code" : "2000100053",
"display" : "More than 3 months"
},
{
"code" : "2000100054",
"display" : "doxorubicin and vincristine "
},
{
"code" : "2000100055",
"display" : "gemcitabine and vincristine"
},
{
"code" : "2000100056",
"display" : "high dose cisplatin"
},
{
"code" : "2000100057",
"display" : "ifosfamide and etoposide"
},
{
"code" : "2000100058",
"display" : "weekly carboplatin"
},
{
"code" : "2000100059",
"display" : "weekly cisplatin"
},
{
"code" : "2000100060",
"display" : "Vincristine and Doxorubicin and Ifosfamide"
},
{
"code" : "2000100061",
"display" : "Methotrexate and Doxorubicin and Cisplatin"
},
{
"code" : "2000100062",
"display" : "Methotrexate and Doxorubicin and Ifosfamide"
},
{
"code" : "2000100063",
"display" : "Doxorubicin and Cisplatin and Ifosfamide"
},
{
"code" : "2000100064",
"display" : "Methotrexate and Vinorelbine"
},
{
"code" : "2000100065",
"display" : "Vincristine and Doxorubicin and Cyclophosphamide"
},
{
"code" : "2000100066",
"display" : "Doxorubicin and Ifosfamide and Dacarbazine"
},
{
"code" : "2000100067",
"display" : "Irinotecan and Vincristine"
},
{
"code" : "2000100068",
"display" : "TNF and Melphalan"
},
{
"code" : "2000100069",
"display" : "Cyclophosphamide and Vinorelbine"
},
{
"code" : "2000100070",
"display" : "high dose Ifosfamide"
},
{
"code" : "2000100071",
"display" : "Alive, No Evidence of Disease (NED)"
},
{
"code" : "2000100072",
"display" : "Dead of Disease (DOD)"
},
{
"code" : "2000100073",
"display" : "Dead of Other Cause (DOC)"
},
{
"code" : "2000100074",
"display" : "Dead of Unknown Cause (DUC)"
},
{
"code" : "2000100075",
"display" : "Alive With Disease (AWD)"
}
]
}
IG © 2022+ IDEA4RC Project. Package hl7.eu.fhir.idea4rc#0.1.0 based on FHIR 4.0.1. Generated 2025-09-10
Links: Table of Contents |
QA Report
The IDEA4RC project has received funding from the European Union's Horizon 2020
research and innovation programme under grant agreement No. 101057048.
